Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Hikma Pharmaceuticals Plc    HIK   GB00B0LCW083

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Hikma Pharmaceuticals : King visits Hikma's New Jersey plant, inaugurates expansion

09/27/2015 | 10:38am US/Eastern

Sept. 27--AMMAN -- His Majesty King Abdullah on Thursday visited the US-based West-Ward Plant in New Jersey, US, a subsidiary of Hikma Pharmaceuticals PLC and its agent in the US.

His Majesty's stop-over at the company came ahead of his arrival in New York to head the Jordanian delegation to the 70th UN General Assembly meeting.

The King met with Hikma Pharmaceuticals' Vice Chairman Mazen Darwazeh and board members, where he was briefed on the Jordanian company's position in international markets and plans of development, a Royal Court statement said.

They also discussed ways to enhance Jordan's pharmaceutical industry and the country's potential as a destination of investments in this field.

Hikma is a multinational pharmaceutical group which was founded in 1978 in Jordan. Its sales worldwide constitute 7 per cent of Jordan's total exports, and 80 per cent of its pharmaceutical expors.

The company's operations expand through 27 manufacturing facilities in 11 countries, including the US. It markets its products in 50 countries across the world.

In 2004, the group reported $1.489 billion in revenues, according to the Royal Court statement.

It hires around 8,500 persons in all its facilities across the world, a third of whom are Jordanians.

His Majesty inaugurated a new extension to the plant and toured the facility, where officials briefed him on its operation and products.

West-Ward Pharmaceuticals, which Hikma acquired in 1991, is a leading generic prescription medication providers in the US offering both oral solid and injectable pharmaceuticals to a growing number of chain stores, wholesalers, distributors, health systems and government agencies, according to the company's website.

Darwazeh said during the King's visit that the facility produces 200 million injectables annually, all sold in the US.


(c)2015 the Jordan Times (Amman, Jordan)

Visit the Jordan Times (Amman, Jordan) at www.jordantimes.com

Distributed by Tribune Content Agency, LLC.

© Tribune Content Agency, source Regional News

React to this article
09/27 HIKMA PHARMACEUTICALS : King visits Hikma's New Jersey plant, inaugurates expans..
09/24 U.S. appeals court upholds Shire's patents on hyperactivity drug
09/18 HIKMA PHARMACEUTICALS : APNewsBreak: Arkansas execution plan may use UK firm's d..
09/08 HIKMA PHARMACEUTICALS : says to buy Egyptian pharma firm EIMC United
09/08 HIKMA PHARMACEUTICALS : Strikes Deal To Buy Egypt's EIMC United
09/08 HIKMA PHARMACEUTICALS : agrees to acquire EIMC United Pharmaceuticals, strengthe..
09/04DJLONDON MARKETS : London Stocks Slide, Cement Weekly Loss
09/04 HIKMA PHARMACEUTICALS : *gs raises hikma pharmaceuticals to 'buy' ('neutral') - ..
09/02 Lannett to buy UCB unit to boost speciality generic drugs portfolio
Duration : Period :
Hikma Pharmaceuticals Plc Technical Analysis Chart | HIK | GB00B0LCW083 | 4-Traders
Income Statement Evolution
More Financials